Cost‐of‐illness of psoriasis – results of a German cross‐sectional study

• DOI: 10.1111/jdv.14543
• Publication Date: 2017-08-31T11:43:27Z
• Authors: D. Jungen; M. Augustin; A. Langenbruch; N. Zander; K. Reich; K. Strömer; D. Thaci; S. Purwins; M. Radtke; M. Gutknecht
• Keywords: Cross-sectional study

Though psoriasis poses a substantial chronic socio-economic burden, few studies have addressed the economic impact in Germany.The objective was to evaluate annual costs of Germany from societal perspective.A cross-sectional study performed randomly selected German dermatology practices and clinics 2013/2014 using standardized questionnaires illness-related costs. Costs were grouped by perspective category as well analysed sex age. Group differences tested non-parametric tests.Complete data obtained 1158 patients 132 centres. Annual average for with psoriasis: total € 5543 ± 8044, systemic treatment (paid statutory health insurances [SHI]) 3733 7322, out-of-pocket 224 406, SHI 4940 7533, direct 5164 7581 indirect 379 2087. Significant higher male significant lower 65+-year-old found.Psoriasis induces considerable burden. Between 2003 2014, markedly shifted hospital, towards drug